The House passed on voice votes July 11 three amendments aimed at addressing concerns about Chinese telecom equipment manufacturers Huawei and ZTE for inclusion in the chamber's version of the fiscal year 2020 National Defense Authorization Act (H.R. 2500). One, led by Rep. Mike Gallagher, R-Wis., would impose conditions for the Department of Commerce to be able to lift the Bureau of Industry and Security's addition of Huawei to its Entity List that would impose export restrictions on the company, including a finding that Huawei and its executives haven't violated U.S. or United Nations sanctions and haven't engaged in theft of U.S. intellectual property during the preceding five years. Acting Commerce Undersecretary for Industry and Security Nazak Nikakhtar said on July 9 the department is reviewing export license applications to sell to Huawei in order to “mitigate as much of the negative impacts of the entity listing as possible” and hopes to have decisions “soon” (see 1907090068).
Senate Finance Committee Chairman Chuck Grassley said that although under fast track authority the administration could send the implementing bill for the NAFTA rewrite on July 9, the administration will not be doing that. "There's respect for this legislative process and the importance of Pelosi involved this process... the White House is not going to do anything without consulting with her," he said. He referred to White House Chief Economic Advisor Larry Kudlow's comments earlier that morning about the administration's plans.
Leaders of the generally pro-trade New Democrat Coalition warned the U.S. trade representative not to send an implementing bill for the new NAFTA to Congress on July 9. Rep. Derek Kilmer, chairman of the New Dems, and Rep. Gregory Meeks, co-chairman of the group's trade task force, spoke to reporters July 8 about why they sent a letter that day to USTR warning him off.
A bipartisan effort to reduce fentanyl trafficking passed the Senate June 27 on the must-pass defense authorization bill. The amendment would dedicate some money for investigations into which Chinese companies are supplying fentanyl to the U.S. black market. It also requires sanctions on drug manufacturers in China that knowingly provide synthetic opioids to dealers, and would sanction financial institutions that assist those manufacturers or international drug cartels. However, Senate Minority Leader Chuck Schumer's staff could not say by press time how much money would be appropriated.
Rep. Mark Green, R-Tenn., plans to introduce a bill that would increase export controls on additional goods deemed by China to be “core technologies,” and impose sanctions on foreign entities or people who violate those controls, according to a "dear colleague" letter Green sent June 26 to solicit co-sponsors. The bill, which he calls the China Technology Transfer Control Act, would “stop the Chinese military’s acquisition of sensitive American technology,” the letter said. “We should not continue to let China steal American property, only for them to turn around and use it to undermine our national security.”
The Senate Committee on Foreign Relations advanced a bill on June 25 that would repeal the ban on all exports to Cyprus that fall on the U.S. Munitions List. The change would prohibit the State Department from denying exports, re-exports or transfers of defense items and services to Cyprus as long as Cyprus is the end-user, the bill states. The repeal would advance U.S. “security interests” in Europe by helping Cyprus reduce its dependence on “other countries” for defense products, including countries that “pose challenges” to the U.S., the bill said. The change comes as part of a larger bill that would require the State Department to submit reports to Congress on Russian interference in Cyprus, Greece and Israel. The bill would also call on the Trump administration to impose sanctions on Turkey and Russia if Turkey carries out its plan to buy an S-400 air defense system from Russia.
House Ways and Means Trade Subcommittee Chairman Earl Blumenauer said he thinks the House could be able to have a vote in the fall on the new NAFTA. Blumenauer, from Oregon and one of nine House Democrats who are tasked with negotiating changes to the deal with U.S. Trade Representative Robert Lighthizer, said he expects the group will meet with USTR "at least once a week." Speaking at a Washington International Trade Association event June 26, he joked that Lighthizer spends so much time meeting with House members and caucuses, "I think he travels the world just to get away from us." Lighthizer is on his way to Osaka, Japan, for the G-20 meeting. He met with the working group the afternoon before he left.
The Senate Foreign Relations Committee advanced a bill on June 25 that would limit the ability of the executive branch to bypass congressional approval of foreign arms sales. The bill, called the Saudi Arabia False Emergencies Act, had bipartisan support and was advanced less than a week after the Senate voted to block billions of dollars worth of arms sales to Saudi Arabia and the United Arab Emirates that the Trump administration had announced May 24 (see 1906200052). The administration had used an emergency provision in the Arms Export Control Act to skip congressional approval.
House Ways and Means Trade Subcommittee Chairman Earl Blumenauer, D-Ore., said after a June 25 hearing on Mexican labor reform that the Democrats asking for changes to the NAFTA rewrite are asking for changes that are "relatively narrow." "Our hope is we can move with dispatch, get our concerns resolved, strengthen the agreement and move forward," he said, adding that trade deal votes "never get easy, putting them off."
NAFTA foe Rep. Rosa DeLauro, who is on the working group seeking changes to the NAFTA replacement, joined with the president of the AFL-CIO, the head of Global Trade Watch, and a handful of progressive House members to say that Americans are demanding that the biologics exclusivity period be dropped from the trade deal.